Pacific Biosciences Of California Shares Outstanding 2009-2018 | PACB
Current and historical number of shares outstanding for Pacific Biosciences Of California (PACB) from 2009 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
| Pacific Biosciences Of California Annual Shares Outstanding (Millions of US $) |
|
|---|---|
| 2017 | $106 |
| 2016 | $89 |
| 2015 | $76 |
| 2014 | $70 |
| 2013 | $63 |
| 2012 | $56 |
| 2011 | $54 |
| 2010 | $10 |
| 2009 | $1 |
| 2008 | $0 |
| 2007 | $0 |
| Pacific Biosciences Of California Quarterly Shares Outstanding (Millions of US $) |
|
|---|---|
| Q2 2018 | $132 |
| Q1 2018 | $124 |
| Q4 2017 | $106 |
| Q3 2017 | $116 |
| Q2 2017 | $97 |
| Q1 2017 | $93 |
| Q4 2016 | $89 |
| Q3 2016 | $92 |
| Q2 2016 | $88 |
| Q1 2016 | $84 |
| Q4 2015 | $76 |
| Q3 2015 | $80 |
| Q2 2015 | $75 |
| Q1 2015 | $74 |
| Q4 2014 | $70 |
| Q3 2014 | $71 |
| Q2 2014 | $71 |
| Q1 2014 | $68 |
| Q4 2013 | $63 |
| Q3 2013 | $66 |
| Q2 2013 | $62 |
| Q1 2013 | $57 |
| Q4 2012 | $56 |
| Q3 2012 | $56 |
| Q2 2012 | $56 |
| Q1 2012 | $55 |
| Q4 2011 | $54 |
| Q3 2011 | $54 |
| Q2 2011 | $53 |
| Q1 2011 | $53 |
| Q4 2010 | $10 |
| Q3 2010 | $1 |
| Q2 2010 | $1 |
| Q1 2010 | $1 |
| Q4 2009 | $0 |
| Q3 2009 | $1 |
| Q4 2008 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.581B | $0.093B |
| Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $93.215B | 22.36 |
| Intuitive Surgical (ISRG) | United States | $59.265B | 56.57 |
| Fresenius Medical Care (FMS) | Germany | $29.358B | 20.74 |
| Edwards Lifesciences (EW) | United States | $28.908B | 32.56 |
| IDEXX Laboratories (IDXX) | United States | $21.087B | 64.08 |
| ABIOMED (ABMD) | United States | $16.956B | 138.91 |
| Hologic (HOLX) | United States | $11.065B | 18.82 |
| DexCom (DXCM) | United States | $10.899B | 0.00 |
| Teleflex (TFX) | United States | $10.447B | 24.85 |
| Varian Medical Systems (VAR) | United States | $10.178B | 25.62 |
| STERIS (STE) | United Kingdom | $9.709B | 26.70 |
| LivaNova (LIVN) | United Kingdom | $5.976B | 35.65 |
| Masimo (MASI) | United States | $5.677B | 37.80 |
| Integra LifeSciences Holdings (IART) | United States | $5.353B | 27.70 |
| Globus Medical (GMED) | United States | $5.144B | 34.22 |
| Inogen (INGN) | United States | $4.848B | 128.30 |
| Penumbra (PEN) | United States | $4.275B | 388.59 |
| Cantel Medical (CMD) | United States | $3.989B | 41.58 |
| Opko Health (OPK) | United States | $3.034B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.990B | 0.00 |
| Halyard Health (AVNS) | United States | $2.966B | 24.41 |
| Integer Holdings (ITGR) | United States | $2.263B | 20.49 |
| Nevro (NVRO) | United States | $1.934B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.644B | 0.00 |
| AxoGen (AXGN) | United States | $1.474B | 0.00 |
| Glaukos (GKOS) | United States | $1.464B | 839.00 |
| Mazor Robotics (MZOR) | Israel | $1.309B | 0.00 |
| Luminex (LMNX) | United States | $1.213B | 35.79 |
| CryoLife (CRY) | United States | $1.208B | 105.97 |
| Accelerate Diagnostics (AXDX) | United States | $1.204B | 0.00 |
| Natus Medical (BABY) | United States | $1.187B | 25.18 |
| Tactile Systems Technology (TCMD) | United States | $1.048B | 178.59 |
| K2Ms (KTWO) | United States | $0.909B | 0.00 |
| Intersect ENT (XENT) | United States | $0.838B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.788B | 29.25 |
| Mesa Laboratories (MLAB) | United States | $0.782B | 48.40 |
| ViewRay (VRAY) | United States | $0.744B | 0.00 |
| Sientra (SIEN) | United States | $0.594B | 0.00 |
| Neuronetics (STIM) | United States | $0.561B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.417B | 0.00 |
| Veracyte (VCYT) | United States | $0.414B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.411B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.376B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.353B | 0.00 |
| Accuray (ARAY) | United States | $0.330B | 0.00 |
| IRadimed (IRMD) | United States | $0.296B | 106.54 |
| RTI Surgical (RTIX) | United States | $0.285B | 56.25 |
| T2 Biosystems (TTOO) | United States | $0.283B | 0.00 |
| Fluidigm (FLDM) | United States | $0.281B | 0.00 |
| Nuvectra (NVTR) | United States | $0.259B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.254B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.213B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.205B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.170B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.160B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.137B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.108B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.102B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.097B | 0.00 |
| EDAP TMS (EDAP) | France | $0.091B | 0.00 |
| Invuity (IVTY) | United States | $0.087B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.082B | 0.00 |
| Neovasc (NVCN) | Canada | $0.067B | 0.00 |
| ConforMIS (CFMS) | United States | $0.061B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.043B | 0.00 |
| Vermillion (VRML) | United States | $0.041B | 0.00 |
| Presbia (LENS) | Ireland | $0.037B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.033B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.031B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.029B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.028B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.026B | 0.00 |
| PAVmed (PAVM) | United States | $0.025B | 0.00 |
| Dynatronics (DYNT) | United States | $0.023B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.013B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.009B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.006B | 0.00 |
| Amedica (AMDA) | United States | $0.002B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.001B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
